A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Academics have been awarded NHMRC funding for research into depression, early childhood health and infectious diseases.
People who ruminated and worried excessively were helped by an online course, a randomised controlled trial found.
Promising results in a trial of ketamine for severe depression could lead to treatment becoming more affordable.
Australia needs to be careful when implementing MDMA and psilocybin therapy, says UNSW researcher Professor Colleen Loo.
The risk of repeat self-harm in young people is highest in the first month after an initial self-harm hospital presentation.
Machine learning algorithms could be more accurate and reliable than conventional methods of predicting suicide risk.
Two Australians with bipolar have been successfully treated with poo transplants, allowing them to come off, or reduce, their medications. Here’s where the science is up to.
Becoming socially withdrawn or acting out are signs your child may be distressed.
A UNSW expert on post-traumatic stress and anxiety explains why this year’s lockdown is affecting everyone – and especially vulnerable groups – differently.